Stock Analysis·← Pickers

CHEK

Check-Cap Ltd.

Check-Cap Ltd. (CHEK) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 77.1 (overbought), with 3/3 trend checks passing.

Price
$1.86
+0.03 (+1.64%)
Day range
$1.77–$1.86
52wk $0.56–$3.13
Volume
39.4K
Avg
Trend score
3/3
Uptrend
RSI (14)
77.1
Overbought
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

CHEK with MA50 and MA200

3.162.521.881.240.6001/1604/1407/1110/0301/26
CHEK2025-01-162026-01-26
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$1.65+92.05% vs price
MA200
$1.16+173.46% vs price
RSI (14)
77.1Overbought zone
MACD Signal
BullishMomentum above signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Valuation

CHEK valuation multiples (TTM)

P/E Ratio
P/S Ratio
P/B Ratio
EV/EBITDA
Valuation multiples are provided by Financial Modeling Prep when available.
Analyst Ratings

CHEK analyst consensus

Avg Price Target
High Target
Low Target
Analyst Coverage
Analyst ratings and price targets are provided by Financial Modeling Prep when available.
Chart Summary
Trend summary for CHEK

Check-Cap Ltd. (CHEK) is still trading in a constructive trend overall. The latest available price is $1.86, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 92.1% and above the 200-day moving average by 173.5%.

Momentum and stretch context

CHEK currently has an RSI reading of 77.1, which points to very strong short-term momentum but also a fairly extended setup. Stocks can stay strong for longer than expected, but this kind of reading often tells beginners not to confuse strength with low-risk entry timing.

What traders may watch next

For traders reviewing CHEK next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.

Company profile

About Check-Cap Ltd.

Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays. This technology is designed to thoroughly examine the internal surface of the colon, aiming to identify precancerous polyps and other structural irregularities. The company's primary offering, the C-Scan system, is composed of three integral parts: the C-Scan Cap, an ingestible X-ray scanning capsule for detecting suspected polyps; the C-Scan Track, a disposable unit that adheres to the patient's back via biocompatible adhesive patches; and the C-Scan View software. This client/server application enables the download of procedural data from the C-Scan Track, performs detailed analysis, and generates comprehensive reports. Check-Cap Ltd. was founded in 2004 and operates from its headquarters in Isfiya, Israel.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
David Lontini
Employees
85
Market cap
$10.9M
Beta
0.46
52-week range
$0.56 – $3.13
Dividend
No
Exchange
NASDAQ
Country
IL
IPO date
4 Mar 2015
ISIN
IL0011336851
CUSIP
M2361E203
Company profile data from Financial Modeling Prep. CHEK listed on NASDAQ.
Share dilution

CHEK shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Mar 2018Dec 2024
Shares outstanding (latest)
5.8M
Since Mar 2018
+6885.7%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. CHEK28 data points from Mar 2018 to Dec 2024.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about CHEK

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.